Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for Leslie H. Cross
1.36
0.00 (0.00%)
Aug 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.35 - 1.39
52 week 1.23 - 1.92
Open 1.36
Vol / Avg. 25,852.00/49,377.00
Mkt cap 135.79M
P/E     -
Div/yield     -
EPS -0.11
Shares 99.85M
Beta 1.68
Inst. own 62%
Aug 4, 2015
Q2 2015 Alphatec Holdings Inc Earnings Call
Aug 4, 2015
Q2 2015 Alphatec Holdings Inc Earnings Release
Jun 26, 2015
Alphatec Holdings Inc Annual Shareholders Meeting (Estimated)
Jun 3, 2015
Alphatec Holdings Inc at Jefferies Global Healthcare Conference
May 19, 2015
Alphatec Holdings Inc at UBS Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -9.38% -6.22%
Operating margin 2.35% 0.89%
EBITD margin - 10.12%
Return on average assets -5.50% -3.63%
Return on average equity -12.91% -8.04%
Employees 450 -
CDP Score - -

Address

5818 El Camino Real
CARLSBAD, CA 92008
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alphatec Holdings, Inc. is a medical technology company. The Company is focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar and intervertebral regions of the spine and covers major spinal disorders and surgical procedures. Its principal product offerings are focused on the global market for orthopedic spinal disorder solutions. In addition to the United States operations, the Company also markets its products in international markets via a direct salesforce in Italy and the United Kingdom, and via independent distributors in the rest of Europe, the Middle East and Africa. In South America and Latin America, the Company conducts its operations through its Brazilian subsidiary. In Asia, the Company markets its products via a direct sales force and independent distributors and through distributors in other parts of Asia and Australia.

Officers and directors

James M. Corbett President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Michael O'Neill Chief Financial Officer, Vice President, Treasurer
Age: 55
Bio & Compensation  - Reuters
Mitsuo Asai President of Alphatec Pacific, Inc.
Age: 60
Bio & Compensation  - Reuters
Michael Plunkett Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Mark Bullivant Senior Vice President - International
Age: 46
Bio & Compensation  - Reuters
Kristin Machacek Leary Senior Vice President - Global Human Resources
Age: 46
Bio & Compensation  - Reuters
Stephen A. Lubischer Vice President - Sales
Age: 52
Bio & Compensation  - Reuters
Leslie H. Cross Non-Executive Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Mortimer Berkowitz III Director
Age: 61
Bio & Compensation  - Reuters